國能日新(301162.SZ):擬870萬元投資天津馭能 對其持股將增至31.75%
格隆匯5月23日丨國能日新(301162.SZ)公佈,公司基於公司發展戰略規劃,擬通過受讓老股及現金增資的方式增加對參股公司天津馭能能源科技有限公司(簡稱“天津馭能”、“投資標的”或“目標公司”)的投資,本次投資金額共計870萬元,資金來源均為公司自有資金。其中,公司擬以150萬元受讓袁彩萍所持有的天津馭能5%的股權;此外,公司擬以720萬元向天津馭能進行現金增資,對應新增持有天津馭能7.42%的股權。本次交易完成後,公司持有天津馭能的股權將由19.33%增加至31.75%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.